Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aditxt Inc ADTX

Healthcare Biotechnology
Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc... see more

Recent & Breaking News (NDAQ:ADTX)

Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th

Business Wire April 5, 2022

Aditxt to Participate in the 2022 Virtual Growth Conference

Business Wire March 23, 2022

ADITXT INVESTOR ALERT - Kuznicki Law PLLC Investigates Adequacy of Price and Process in Proposed Sale of Aditxt, Inc. - ADTX

Business Wire March 10, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TMX, SKIL, OCDX, ADTX, MIME

PR Newswire March 7, 2022

ADITXT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Aditxt, Inc. - ADTX

Business Wire March 2, 2022

Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore(TM) for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron

Business Wire January 18, 2022

Aditxt, Inc. to Participate in Edison Group's Global Healthcare "Open House" Virtual Conference From January 25th-27th, 2022

Business Wire January 14, 2022

Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO

Business Wire January 12, 2022

SHAREHOLDER ALERT: WeissLaw LLP Reminds ADTX, LAWS, MNR, and MCFE Shareholders About Its Ongoing Investigations

PR Newswire January 11, 2022

Halper Sadeh LLP Investigates EPAY, VRS, HXOH, OCDX, ADTX; Shareholders are Encouraged to Contact the Firm

PR Newswire January 11, 2022

Shareholder Alert: The M&A Class Action Firm Announces an Investigation of the Merger

PR Newswire January 10, 2022

ADITXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Aditxt, Inc. - ADTX

PR Newswire January 4, 2022

SHAREHOLDER ALERT: WeissLaw LLP Reminds ADTX, LAWS, BPMP, and CSPR Shareholders About Its Ongoing Investigations

PR Newswire January 4, 2022

Halper Sadeh LLP Investigates LAWS, ADTX, SKIL, VRS, BRG; Shareholders are Encouraged to Contact the Firm

PR Newswire January 4, 2022

Halper Sadeh LLP Investigates LAWS, ADTX, EPAY, SKIL, HXOH; Shareholders are Encouraged to Contact the Firm

PR Newswire December 30, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates Aditxt, Inc.

PR Newswire December 29, 2021

Aditxt Signs Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use

Business Wire December 29, 2021

Aditxt (ADTX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Aditxt Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - ADTX

Business Wire December 28, 2021

Aditxt Signs Share Exchange Agreement to Acquire AiPharma

Business Wire December 28, 2021

Aditxt, Inc. Signs Non-Binding Letter of Intent to Acquire Point-of-Care Diagnostic Technology Development Company

Business Wire December 13, 2021